已批准和临床晚期RNA疗法的趋势和共同点
Maxime Tufeu1,2,3, Christophe Herkenne3, Yogeshvar N Kalia1,2
1School of Pharmaceutical Sciences, University of Geneva, 1211 Geneva, Switzerland.
Pharmaceutics
|July 30, 2025
概括
使者RNA (mRNA) 和其他核酸治疗药物显示出希望,但面临着交付挑战. 分子设计和有针对性的输送策略的进步对于克服内体逃生和提高疗效等局限性至关重要.
科学领域:
- 生物技术和制药科学 生物技术和制药科学
- 分子医学是分子医学.
- 药物输送系统 药物输送系统
背景情况:
- 随着COVID-19大流行,信使RNA (mRNA) 和其他核酸治疗药物 (例如,反感性寡核酸,小干扰RNA,阿普坦) 得到了突出地位.
- 这些模式的关键局限性包括它们固有的结构脆弱性和需要细胞内作用,特别是克服内体逃生.
- 有效的交付仍然是基于核酸的疗法临床成功的关键障碍.
研究的目的:
- 审查和评估成功的和新兴的核酸治疗药物的输送策略.
- 确定需要进一步研究核酸药物输送的领域.
- 分析已批准的和临床晚期核酸治疗药物的输送数据.
主要方法:
- 收集和分析已批准的和临床阶段晚期的核核酸治疗药物的与输送有关的数据.
- 审查用于克服分娩挑战的策略,包括内体逃生.
- 评估分子设计的进步和管理技术.
主要成果:
- 特定的向分量,如用于肝脏的N-乙糖氨,已显示出显著的疗效.
- 分子设计的改进已经产生了"类似药物的"特性,使得在某些情况下可以使用裸核酸.
- 局部管理 (例如注射) 提供实际向和高局部度,弥补了有限的细胞质输送.
结论:
- 核酸治疗药物在物理化学特性方面取得了重大进展.
- 尽管取得了进展,但固有的局限性需要有效的向策略,以获得最佳的治疗疗效.
- 针对性对核酸疗法至关重要,可能比常规药物更重要.
相关概念视频
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:26Drug Administration and Therapy Phases: Overview
753
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
753
01:28Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
176
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
176